BG Medicine, Inc. (OTCMKTS:BGMD – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 100 shares trading hands.
BG Medicine Stock Up 9,900.0 %
About BG Medicine
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Further Reading
- Five stocks we like better than BG Medicine
- What is the S&P 500 and How It is Distinct from Other Indexes
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is the Nikkei 225 index?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20221026145512&h=45&w=95&zc=2){kind=logo}